224 related articles for article (PubMed ID: 2712059)
1. Evaluation of the policy of empiric treatment of suspected Toxoplasma encephalitis in patients with the acquired immunodeficiency syndrome.
Cohn JA; McMeeking A; Cohen W; Jacobs J; Holzman RS
Am J Med; 1989 May; 86(5):521-7. PubMed ID: 2712059
[TBL] [Abstract][Full Text] [Related]
2. Long-term follow-up of patients with AIDS on maintenance therapy for toxoplasmosis.
Leport C; Tournerie C; Raguin G; Fernandez-Martin J; Niyongabo T; Vildé JL
Eur J Clin Microbiol Infect Dis; 1991 Mar; 10(3):191-3. PubMed ID: 2060528
[TBL] [Abstract][Full Text] [Related]
3. AIDS commentary. Toxoplasmic encephalitis.
Luft BJ; Remington JS
J Infect Dis; 1988 Jan; 157(1):1-6. PubMed ID: 3121758
[No Abstract] [Full Text] [Related]
4. Treatment of acute toxoplasmosis with intravenous clindamycin. The California Collaborative Treatment Group.
Dannemann BR; McCutchan JA; Israelski DM; Antoniskis D; Leport C; Luft BJ; Chiu J; Vildé JL; Nussbaum JN; Orellana M
Eur J Clin Microbiol Infect Dis; 1991 Mar; 10(3):193-5. PubMed ID: 2060529
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the efficacy and safety of clindamycin plus pyrimethamine for induction and maintenance therapy of toxoplasmic encephalitis in AIDS.
Katlama C
Eur J Clin Microbiol Infect Dis; 1991 Mar; 10(3):189-91. PubMed ID: 2060527
[TBL] [Abstract][Full Text] [Related]
6. Toxoplasmic encephalitis in AIDS.
Dannemann BR; Remington JS
Hosp Pract (Off Ed); 1989 Mar; 24(3):139-47, 151-4. PubMed ID: 2493464
[No Abstract] [Full Text] [Related]
7. Toxoplasma encephalitis in patients with acquired immune deficiency syndrome: diagnosis and response to therapy.
Wanke C; Tuazon CU; Kovacs A; Dina T; Davis DO; Barton N; Katz D; Lunde M; Levy C; Conley FK
Am J Trop Med Hyg; 1987 May; 36(3):509-16. PubMed ID: 3495190
[TBL] [Abstract][Full Text] [Related]
8. Role of clindamycin in the treatment of central nervous system toxoplasmosis.
Rolston KV; Hoy J
Am J Med; 1987 Sep; 83(3):551-4. PubMed ID: 3661590
[TBL] [Abstract][Full Text] [Related]
9. A retrospective study of primary and maintenance therapy of toxoplasmic encephalitis with oral clindamycin and pyrimethamine.
Foppa CU; Bini T; Gregis G; Lazzarin A; Esposito R; Moroni M
Eur J Clin Microbiol Infect Dis; 1991 Mar; 10(3):187-9. PubMed ID: 2060526
[TBL] [Abstract][Full Text] [Related]
10. Comparison of two medications in central nervous system toxoplasmosis in patients with AIDS.
Antinori A; Ammassari A; Maiuro G; Camilli G; Damiano F; Federico G; Pizzigallo E; Tamburrini E
Ital J Neurol Sci; 1992 Sep; 13(6):475-9. PubMed ID: 1428784
[TBL] [Abstract][Full Text] [Related]
11. Cerebral toxoplasmosis in the acquired immune deficiency syndrome.
Carrazana EJ; Rossitch E; Samuels MA
Clin Neurol Neurosurg; 1989; 91(4):291-301. PubMed ID: 2555089
[TBL] [Abstract][Full Text] [Related]
12. Treatment of Toxoplasma brain abscess with clindamycin and sulfadiazine in an AIDS patient with concurrent atypical Pneumocystis carinii pneumonia.
Tsai HC; Lee SS; Lin HH; Lin WR; Chen YS; Huang CK; Liu YC; Chen ER
J Formos Med Assoc; 2002 Sep; 101(9):646-9. PubMed ID: 12645193
[TBL] [Abstract][Full Text] [Related]
13. Sulfadiazine-induced crystalluria in AIDS patients with toxoplasma encephalitis.
Molina JM; Belenfant X; Doco-Lecompte T; Idatte JM; Modai J
AIDS; 1991 May; 5(5):587-9. PubMed ID: 1863412
[TBL] [Abstract][Full Text] [Related]
14. Toxoplasmic encephalitis in patients with the acquired immunodeficiency syndrome. Members of the ACTG 077p/ANRS 009 Study Team.
Luft BJ; Hafner R; Korzun AH; Leport C; Antoniskis D; Bosler EM; Bourland DD; Uttamchandani R; Fuhrer J; Jacobson J
N Engl J Med; 1993 Sep; 329(14):995-1000. PubMed ID: 8366923
[TBL] [Abstract][Full Text] [Related]
15. Treatment of central nervous system toxoplasmosis with pyrimethamine/sulfadiazine combination in 35 patients with the acquired immunodeficiency syndrome. Efficacy of long-term continuous therapy.
Leport C; Raffi F; Matheron S; Katlama C; Regnier B; Saimot AG; Marche C; Vedrenne C; Vilde JL
Am J Med; 1988 Jan; 84(1):94-100. PubMed ID: 3337134
[TBL] [Abstract][Full Text] [Related]
16. Sulfadiazine crystalluria revisited. The treatment of Toxoplasma encephalitis in patients with acquired immunodeficiency syndrome.
Simon DI; Brosius FC; Rothstein DM
Arch Intern Med; 1990 Nov; 150(11):2379-84. PubMed ID: 2241449
[TBL] [Abstract][Full Text] [Related]
17. A study for precision diagnosing and treatment strategies in difficult-to-treat AIDS cases and HIV-infected patients with highly fatal or highly disabling opportunistic infections.
Li Y; Zeng YM; Lu YQ; Qin YY; Chen YK
Medicine (Baltimore); 2020 May; 99(20):e20146. PubMed ID: 32443329
[TBL] [Abstract][Full Text] [Related]
18. Toxoplasmic encephalitis in patients with AIDS.
Israelski DM; Remington JS
Infect Dis Clin North Am; 1988 Jun; 2(2):429-45. PubMed ID: 3060527
[TBL] [Abstract][Full Text] [Related]
19. Determination of the inhibitory effect on Toxoplasma growth in the serum of AIDS patients during acute therapy for toxoplasmic encephalitis.
Derouin F; Gérard L; Farinotti R; Maslo C; Leport C
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Sep; 19(1):50-4. PubMed ID: 9732069
[TBL] [Abstract][Full Text] [Related]
20. Toxoplasmosis in AIDS patients.
Tuazon CU
J Antimicrob Chemother; 1989 Jan; 23 Suppl A():77-82. PubMed ID: 2654118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
